Open AccessSO019EFFECTS OF EMPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME® TRIAL
Author(s) -
Vlado Perkovic,
Adeera Levin,
David C. Wheeler,
Audrey KoitkaWeber,
Michaela Mattheus,
Jyothis T. George,
Maximilian von Eynatten,
Christoph Wanner
Publication year - 2017
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfx103
Subject(s) - empagliflozin , medicine , empa , outcome (game theory) , diabetes mellitus , type 2 diabetes , endocrinology , chemistry , mineralogy , mathematics , mathematical economics , electron microprobe
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom